31 Jan US FDA grants breakthrough therapy designation for Moderna’s RSV vaccine
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Moderna’s investigational mRNA vaccine for respiratory syncytial virus (RSV) in adult patients....